Protein Summary
Thiol protease that cleaves IL-1 beta between an Asp and an Ala, releasing the mature cytokine which is involved in a variety of inflammatory processes. Important for defense against pathogens. Cleaves and activates sterol regulatory element binding proteins (SREBPs). Can also promote apoptosis. Upon inflammasome activation, during DNA virus infection but not RNA virus challenge, controls antiviral immunity through the cleavage of CGAS, rendering it inactive (PubMed:28314590). This gene encodes a protein which is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce 2 subunits, large and small, that dimerize to form the active enzyme. This gene was identified by its ability to proteolytically cleave and activate the inactive precursor of interleukin-1, a cytokine ...more
- ENST00000353247
- ENSP00000344132
- ENSG00000137752
- ENST00000436863
- ENSP00000410076
- ENST00000446369
- ENSP00000403260
- ENST00000525825
- ENSP00000434779
- ENST00000526568
- ENSP00000434250
- ENST00000531166
- ENSP00000434303
- ENST00000533400
- ENSP00000433138
- ENST00000534497
- ENSP00000436875
- IL1BC
- IL1BCE
- ICE
- P45
- IL1BC
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
virus perturbation | 1 | ||
protein domain | 0.99 | ||
biological process | 0.94 | ||
chemical | 0.93 | ||
transcription factor perturbation | 0.88 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 3266.99 (req: < 5)
Gene RIFs: 232 (req: <= 3)
Antibodies: 1028 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 3266.99 (req: >= 5)
Gene RIFs: 232 (req: > 3)
Antibodies: 1028 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 25
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 406
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 1